{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:55:36Z","timestamp":1791255336309,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,4,11]],"date-time":"2011-04-11T00:00:00Z","timestamp":1302480000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2011,4,11]],"date-time":"2011-04-11T00:00:00Z","timestamp":1302480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Although <jats:italic>Pseudomonas aeruginosa<\/jats:italic> is a leading pathogen responsible for ventilator-associated pneumonia (VAP), the excess in mortality associated with multi-resistance in patients with <jats:italic>P. aeruginosa<\/jats:italic> VAP (PA-VAP), taking into account confounders such as treatment adequacy and prior length of stay in the ICU, has not yet been adequately estimated.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>A total of 223 episodes of PA-VAP recorded into the Outcomerea database were evaluated. Patients with ureido\/carboxy-resistant <jats:italic>P. aeruginosa<\/jats:italic> (PRPA) were compared with those with ureido\/carboxy-sensitive <jats:italic>P. aeruginosa<\/jats:italic> (PSPA) after matching on duration of ICU stay at VAP onset and adjustment for confounders.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Factors associated with onset of PRPA-VAP were as follows: admission to the ICU with septic shock, broad-spectrum antimicrobials at admission, prior use of ureido\/carboxypenicillin, and colonization with PRPA before infection. Adequate antimicrobial therapy was more often delayed in the PRPA group. The crude ICU mortality rate and the hospital mortality rate were not different between the PRPA and the PSPA groups. In multivariate analysis, after controlling for time in the ICU before VAP diagnosis, neither ICU death (odds ratio (OR) = 0.73; 95% confidence interval (CI): 0.32 to 1.69; <jats:italic>P<\/jats:italic> = 0.46) nor hospital death (OR = 0.87; 95% CI: 0.38 to 1.99; <jats:italic>P<\/jats:italic> = 0.74) were increased in the presence of PRPA infection. This result remained unchanged in the subgroup of 87 patients who received adequate antimicrobial treatment on the day of VAP diagnosis.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>After adjustment, and despite the more frequent delay in the initiation of an adequate antimicrobial therapy in these patients, resistance to ureido\/carboxypenicillin was not associated with ICU or hospital death in patients with PA-VAP.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/cc10136","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T18:54:27Z","timestamp":1302634467000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Impact of ureido\/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa"],"prefix":"10.1186","volume":"15","author":[{"given":"Catherine","family":"Kaminski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Timsit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohann","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Ralph","family":"Zahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00eft\u00e9","family":"Garrouste-Orgeas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Vesin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elie","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Feger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sylvie","family":"Dumenil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Adrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Allaouchiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the OUTCOMEREA study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,11]]},"reference":[{"key":"9435_CR1","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.ajic.2004.10.001","volume":"32","author":"NNIS","year":"2004","unstructured":"NNIS: National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004.\n                           Am J Infect Control 2004, 32: 470-485.","journal-title":"Am J Infect Control"},{"key":"9435_CR2","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","volume":"165","author":"J Chastre","year":"2002","unstructured":"Chastre J, Fagon JY: Ventilator-associated pneumonia.\n                           Am J Respir Crit Care Med 2002, 165: 867-903.","journal-title":"Am J Respir Crit Care Med"},{"key":"9435_CR3","unstructured":"REA-RAISIN Annual report 2009[http:\/\/www.cclinparisnord.org\/REACAT\/REA2009\/rea_raisin_resultats2009.pdf]"},{"key":"9435_CR4","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1126\/science.8493556","volume":"260","author":"L Passador","year":"1993","unstructured":"Passador L, Cook JM, Gambello MJ, Rust L, Iglewski BH: Expression of\n                           Pseudomonas aeruginosa\n                           virulence genes requires cell-to-cell communication.\n                           Science (New York, NY) 1993, 260: 1127-1130. 10.1126\/science.8493556","journal-title":"Science (New York, NY)"},{"key":"9435_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.micpath.2010.05.013","volume":"49","author":"G Singh","year":"2010","unstructured":"Singh G, Wu B, Baek MS, Camargo A, Nguyen A, Slusher NA, Srinivasan R, Wiener-Kronish JP, Lynch SV: Secretion of\n                           Pseudomonas aeruginosa\n                           type III cytotoxins is dependent on pseudomonas quinolone signal concentration.\n                           Microb Pathog 2010, 49: 196-203. 10.1016\/j.micpath.2010.05.013","journal-title":"Microb Pathog"},{"key":"9435_CR6","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1136\/thx.2009.133082","volume":"65","author":"T Kohler","year":"2010","unstructured":"Kohler T, Guanella R, Carlet J, van Delden C: Quorum sensing-dependent virulence during\n                           Pseudomonas aeruginosa\n                           colonisation and pneumonia in mechanically ventilated patients.\n                           Thorax 2010, 65: 703-710. 10.1136\/thx.2009.133082","journal-title":"Thorax"},{"key":"9435_CR7","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/00003246-200203000-00005","volume":"30","author":"AR Hauser","year":"2002","unstructured":"Hauser AR, Cobb E, Bodi M, Mariscal D, Valles J, Engel JN, Rello J: Type III protein secretion is associated with poor clinical outcomes in patients with ventilator-associated pneumonia caused by\n                           Pseudomonas aeruginosa\n                           .\n                           Crit Care Med 2002, 30: 521-528. 10.1097\/00003246-200203000-00005","journal-title":"Crit Care Med"},{"key":"9435_CR8","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1128\/MMBR.00027-10","volume":"74","author":"VL Kung","year":"2010","unstructured":"Kung VL, Ozer EA, Hauser AR: The accessory genome of\n                           Pseudomonas aeruginosa\n                           .\n                           Microbiol Mol Biol Rev 2010, 74: 621-641. 10.1128\/MMBR.00027-10","journal-title":"Microbiol Mol Biol Rev"},{"key":"9435_CR9","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1007\/s00134-006-0355-7","volume":"32","author":"A Combes","year":"2006","unstructured":"Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Chastre J: Impact of piperacillin resistance on the outcome of\n                           Pseudomonas\n                           ventilator-associated pneumonia.\n                           Intensive Care Med 2006, 32: 1970-1978. 10.1007\/s00134-006-0355-7","journal-title":"Intensive Care Med"},{"key":"9435_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1086\/339488","volume":"34","author":"JL Trouillet","year":"2002","unstructured":"Trouillet JL, Vuagnat A, Combes A, Kassis N, Chastre J, Gibert C: Pseudomonas aeruginosa\n                           ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms.\n                           Clin Infect Dis 2002, 34: 1047-1054. 10.1086\/339488","journal-title":"Clin Infect Dis"},{"key":"9435_CR11","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","volume":"13","author":"WA Knaus","year":"1985","unstructured":"Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system.\n                           Crit Care Med 1985, 13: 818-829. 10.1097\/00003246-198510000-00009","journal-title":"Crit Care Med"},{"key":"9435_CR12","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1001\/jama.1993.03510240069035","volume":"270","author":"JR Le Gall","year":"1993","unstructured":"Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European\/North American multicenter study.\n                           JAMA 1993, 270: 2957-2963. 10.1001\/jama.270.24.2957","journal-title":"JAMA"},{"key":"9435_CR13","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1097\/00003246-200209000-00009","volume":"30","author":"JF Timsit","year":"2002","unstructured":"Timsit JF, Fosse JP, Troche G, De Lassence A, Alberti C, Garrouste-Orgeas M, Bornstain C, Adrie C, Cheval C, Chevret S: Calibration and discrimination by daily Logistic Organ Dysfunction scoring comparatively with daily Sequential Organ Failure Assessment scoring for predicting hospital mortality in critically ill patients.\n                           Crit Care Med 2002, 30: 2003-2013. 10.1097\/00003246-200209000-00009","journal-title":"Crit Care Med"},{"key":"9435_CR14","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1097\/CCM.0b013e3181a38109","volume":"37","author":"JR Zahar","year":"2009","unstructured":"Zahar JR, Nguile-Makao M, Francais A, Schwebel C, Garrouste-Orgeas M, Goldgran-Toledano D, Azoulay E, Thuong M, Jamali S, Cohen Y, de Lassence A, Timsit JF: Predicting the risk of documented ventilator-associated pneumonia for benchmarking: construction and validation of a score.\n                           Crit Care Med 2009, 37: 2545-2551. 10.1097\/CCM.0b013e3181a38109","journal-title":"Crit Care Med"},{"key":"9435_CR15","unstructured":"OUTCOMEREA: the matching N:M macro using the SAS software[http:\/\/www.outcomerea.org\/Telecharger-document\/286-Matching-NM.html]"},{"key":"9435_CR16","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.1086\/320186","volume":"32","author":"AC Gales","year":"2001","unstructured":"Gales AC, Jones RN, Turnidge J, Rennie R, Ramphal R: Characterization of\n                           Pseudomonas aeruginosa\n                           Isolates: Occurence Rates, Antimicrobial Susceptibility Patterns, and Molecular Typing in the Global SENTRY Antimicrobial Surveillance Program, 1997-1999.\n                           Clin Infect Dis 2001, 32: S146-155. 10.1086\/320186","journal-title":"Clin Infect Dis"},{"key":"9435_CR17","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1007\/s001340051111","volume":"26","author":"JL Vincent","year":"2000","unstructured":"Vincent JL: Microbial resistance: lessons from the EPIC study. European Prevalence of Infection.\n                           Intensive Care Med 2000, 26: S3-8. 10.1007\/s001340051111","journal-title":"Intensive Care Med"},{"key":"9435_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1084\/jem.20020005","volume":"196","author":"Y Hirataka","year":"2002","unstructured":"Hirataka Y, Srikumar R, Poole K, Gotoh N, Suematsu T, Kohno S, Kamihira S, Hancock RE, Speert DP: Multidrug efflux systems play an important role in the invasiveness of\n                           Pseudomonas aeruginosa\n                           .\n                           J Exp Med 2002, 196: 109-118. 10.1084\/jem.20020005","journal-title":"J Exp Med"},{"key":"9435_CR19","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/jac\/dkf185","volume":"50","author":"P Sanchez","year":"2002","unstructured":"Sanchez P, Linares JF, Ruiz-Diez B, Campanario E, Navas A, Baquero F, Martinez JL: Fitness of\n                           in vitro\n                           selected\n                           Pseudomonas aeruginosa\n                           nalB and nfxB multidrug resistant mutants.\n                           J Antimicrob Chemother 2002, 50: 657-664. 10.1093\/jac\/dkf185","journal-title":"J Antimicrob Chemother"},{"key":"9435_CR20","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1128\/JB.187.4.1384-1391.2005","volume":"187","author":"JF Linares","year":"2005","unstructured":"Linares JF, Lopez JA, Camafeita E, Albar JP, Rojo F, Martinez JL: Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in\n                           Pseudomonas aeruginosa\n                           .\n                           J Bacteriol 2005, 187: 1384-1391. 10.1128\/JB.187.4.1384-1391.2005","journal-title":"J Bacteriol"},{"key":"9435_CR21","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1128\/AAC.00503-07","volume":"51","author":"D Hocquet","year":"2007","unstructured":"Hocquet D, Berthelot P, Roussel-Delvallez M, Favre R, Jeannot K, Bajolet O, Marty N, Grattard F, Mariani-Kurkdjian P, Bingen E, Husson MO, Couetdic G, Pl\u00e9siat P: Pseudomonas aeruginosa\n                           may accumulate drug resistance mechanisms without losing its ability to cause bloodstream infections.\n                           Antimicrob Agents Chemother 2007, 51: 3531-3536. 10.1128\/AAC.00503-07","journal-title":"Antimicrob Agents Chemother"},{"key":"9435_CR22","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1128\/AAC.01107-07","volume":"52","author":"K Jeannot","year":"2008","unstructured":"Jeannot K, Elsen S, K\u00f6hler T, Attree I, van Delden C, Pl\u00e9siat P: Resistance and virulence of\n                           Pseudomonas aeruginosa\n                           clinical strains overproducing the MexCD-OprJ efflux pump.\n                           Antimicrob Agents Chemother 2008, 52: 2455-2462. 10.1128\/AAC.01107-07","journal-title":"Antimicrob Agents Chemother"},{"key":"9435_CR23","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1097\/01.CCM.0000275389.31974.22","volume":"35","author":"J Garnacho-Montero","year":"2007","unstructured":"Garnacho-Montero J, Sa-Borges M, Sole-Violan J, Barcenilla F, Escoresca-Ortega A, Ochoa M, Cayuela A, Rello J: Optimal management therapy for\n                           Pseudomonas aeruginosa\n                           ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.\n                           Crit Care Med 2007, 35: 1888-1895. 10.1097\/01.CCM.0000275389.31974.22","journal-title":"Crit Care Med"},{"key":"9435_CR24","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1086\/377200","volume":"37","author":"CI Kang","year":"2003","unstructured":"Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, Kim EC, Choe KW: Pseudomonas aeruginosa\n                           bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.\n                           Clin Infect Dis 2003, 37: 745-751. 10.1086\/377200","journal-title":"Clin Infect Dis"},{"key":"9435_CR25","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1007\/s00134-004-2292-7","volume":"30","author":"C Clec'h","year":"2004","unstructured":"Clec'h C, Timsit JF, De Lassence A, Azoulay E, Alberti C, Garrouste-Orgeas M, Mourvilier B, Troche G, Tafflet M, Tuil O, Cohen Y: Efficacy of adequate early antibiotic therapy in ventilator-associated pneumonia: influence of disease severity.\n                           Intensive Care Med 2004, 30: 1327-1333. 10.1007\/s00134-004-2292-7","journal-title":"Intensive Care Med"},{"key":"9435_CR26","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00134-010-1824-6","volume":"36","author":"M Nguile-Makao","year":"2010","unstructured":"Nguile-Makao M, Zahar JR, Francais A, Tabah A, Garrouste-Orgeas M, Allaouchiche B, Goldgran-Toledano D, Azoulay E, Adrie C, Jamali S, Clec'h C, Souweine B, Timsit JF: Attributable mortality of ventilator-associated pneumonia: respective impact of main characteristics at ICU admission and VAP onset using conditional logistic regression and multi-state models.\n                           Intensive Care Med 2010, 36: 781-789. 10.1007\/s00134-010-1824-6","journal-title":"Intensive Care Med"},{"key":"9435_CR27","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1128\/AAC.49.4.1306-1311.2005","volume":"49","author":"ST Micek","year":"2005","unstructured":"Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH: Pseudomonas aeruginosa\n                           bloodstream infection: importance of appropriate initial antimicrobial treatment.\n                           Antimicrob Agents Chemother 2005, 49: 1306-1311. 10.1128\/AAC.49.4.1306-1311.2005","journal-title":"Antimicrob Agents Chemother"},{"key":"9435_CR28","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1086\/340616","volume":"34","author":"S Blot","year":"2002","unstructured":"Blot S, Vandewoude K, De Bacquer D, Colardyn F: Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization.\n                           Clin Infect Dis 2002, 34: 1600-1606. 10.1086\/340616","journal-title":"Clin Infect Dis"},{"key":"9435_CR29","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1097\/01.CCM.0000060015.77443.31","volume":"31","author":"DP Raymond","year":"2003","unstructured":"Raymond DP, Pelletier SJ, Crabtree TD, Evans HL, Pruett TL, Sawyer RG: Impact of antibiotic-resistant gram-negative bacilli infections on outcome in hospitalized patients.\n                           Crit Care Med 2003, 31: 1035-1041. 10.1097\/01.CCM.0000060015.77443.31","journal-title":"Crit Care Med"},{"key":"9435_CR30","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1086\/496923","volume":"41","author":"JR Zahar","year":"2005","unstructured":"Zahar JR, Clec'h C, Tafflet M, Garrouste-Orgeas M, Jamali S, Mourvillier B, De Lassence A, Descorps-Declere A, Adrie C, Costa de Beauregard MA, Azoulay E, Schwebel C, Timsit JF, Outcomerea Study Group: Is methicillin resistance associated with a worse prognosis in\n                           Staphylococcus aureus\n                           ventilator-associated pneumonia?\n                           Clin Infect Dis 2005, 41: 1224-1231. 10.1086\/496923","journal-title":"Clin Infect Dis"},{"key":"9435_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1128\/AAC.50.1.43-48.2006","volume":"50","author":"V Aloush","year":"2006","unstructured":"Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y: Multidrug-resistant\n                           Pseudomonas aeruginosa\n                           : risk factors and clinical impact.\n                           Antimicrob Agents Chemother 2006, 50: 43-48. 10.1128\/AAC.50.1.43-48.2006","journal-title":"Antimicrob Agents Chemother"},{"key":"9435_CR32","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/AAC.43.6.1379","volume":"43","author":"Y Carmeli","year":"1999","unstructured":"Carmeli Y, Troillet N, Eliopoulos GM, Samore MH: Emergence of antibiotic resistant\n                           Pseudomonas aeruginosa\n                           : comparison of risks associated with different antipseudomonal agents.\n                           Antimicrob Agents Chemother 1999, 43: 1379-1382.","journal-title":"Antimicrob Agents Chemother"},{"key":"9435_CR33","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1128\/AAC.46.3.854-858.2002","volume":"46","author":"AD Harris","year":"2002","unstructured":"Harris AD, Perencevich E, Roghmann MC, Morris G, Kaye KS, Johnson JA: Risk factor for piperacillin-tazobactam-resistant\n                           Pseudomonas aeruginosa\n                           among hospitalized patients.\n                           Antimicrob Agents Chemother 2002, 46: 854-858. 10.1128\/AAC.46.3.854-858.2002","journal-title":"Antimicrob Agents Chemother"},{"key":"9435_CR34","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1128\/AAC.01278-06","volume":"51","author":"A Reinhardt","year":"2007","unstructured":"Reinhardt A, Kohler T, Wood P, Rohner P, Dumas JL, Ricou B, van Delden C: Development and persistence of antimicrobial resistance in\n                           Pseudomonas aeruginosa\n                           : a longitudinal observation in mechanically ventilated patients.\n                           Antimicrob Agents Chemother 2007, 51: 1341-1350. 10.1128\/AAC.01278-06","journal-title":"Antimicrob Agents Chemother"},{"key":"9435_CR35","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1086\/324346","volume":"33","author":"EB El Amari","year":"2001","unstructured":"El Amari EB, Chamot E, Auckenthaler R, Pech\u00e8re JC, van Delden C: Influence of previous exposure to antibiotic therapy on the susceptibility pattern of\n                           Pseudomonas aeruginosa\n                           bacteremic isolates.\n                           Clin Infect Dis 2001, 33: 1859-1864. 10.1086\/324346","journal-title":"Clin Infect Dis"},{"key":"9435_CR36","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1128\/AAC.00511-08","volume":"52","author":"M Sugimura","year":"2008","unstructured":"Sugimura M, Maseda H, Hanaki H, Nakae T: Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in\n                           Pseudomonas aeruginosa\n                           .\n                           Antimicrob Agents Chemother 2008, 52: 4141-4144. 10.1128\/AAC.00511-08","journal-title":"Antimicrob Agents Chemother"},{"key":"9435_CR37","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1128\/CMR.00040-09","volume":"22","author":"PD Lister","year":"2009","unstructured":"Lister PD, Wolter DJ, Hanson ND: Antibacterial-resistant\n                           Pseudomonas aeruginosa\n                           : clinical impact and complex regulation of chromosomally encoded resistance mechanisms.\n                           Clin Microbiol Rev 2009, 22: 582-610. 10.1128\/CMR.00040-09","journal-title":"Clin Microbiol Rev"},{"key":"9435_CR38","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1086\/381550","volume":"38","author":"E Paramythiotou","year":"2004","unstructured":"Paramythiotou E, Lucet JC, Timsit JF, Vanjak D, Paugam-Burtz C, Trouillet JL, Belloc S, Kassis N, Karabinis A, Andremont A: Acquisition of multidrug-resistant\n                           Pseudomonas aeruginosa\n                           in patients in intensive care units: role of antibiotics with antipseudomonal activity.\n                           Clin Infect Dis 2004, 38: 670-677. 10.1086\/381550","journal-title":"Clin Infect Dis"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc10136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/cc10136\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/cc10136.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T12:26:44Z","timestamp":1728304004000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/cc10136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,11]]},"references-count":38,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,4]]}},"alternative-id":["9435"],"URL":"https:\/\/doi.org\/10.1186\/cc10136","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,11]]},"assertion":[{"value":"13 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R112"}}